Frazier Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Frazier Management’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,667,242	Closed	-$60M	–	31
2021 Q4	$60M	Hold	4,667,242	–	–	4.62%	5
2021 Q3	$50.4M	Buy	4,667,242 +3,636,364	+353%	+$33.1M	4.03%	8
2021 Q2	$9.41M	Hold	1,030,878	–	–	0.87%	21
2021 Q1	$9.72M	Sell	1,030,878 -1,030,880	-50%	-$14.2M	0.78%	21
2020 Q4	$8.12M	Hold	2,061,758	–	–	0.63%	24
2020 Q3	$5.46M	Hold	2,061,758	–	–	0.49%	19
2020 Q2	$13.7M	Hold	2,061,758	–	–	1.2%	15
2020 Q1	$12M	Hold	2,061,758	–	–	1.36%	11
2019 Q4	$18.5M	Hold	2,061,758	–	–	3.1%	7
2019 Q3	$17.8M	Hold	2,061,758	–	–	5.57%	7
2019 Q2	$23M	Hold	2,061,758	–	–	5.89%	5
2019 Q1	$27.4M	Hold	2,061,758	–	–	6.6%	4
2018 Q4	$31.9M	Sell	2,061,758 -4	-0%	-$76	8.22%	4
2018 Q3	$29.4M	Buy	+2,061,762	New	+$29.4M	5.38%	4

Other funds holding GRTS

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Frazier Management's GRTS Position: Q1 2022 in Review

Frazier Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2022, closing a stake of 4,667,242 shares — an estimated $60M sold.

Frazier Management first reported a position in GRTS in Q3 2018 and held it in 14 quarters. The position peaked at $60M in Q4 2021. 117 funds tracked by Wall St. Rank hold GRTS as of Q1 2022.

Frazier Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Frazier Management sold 4,667,242 Gritstone bio, Inc. Common Stock shares in Q1 2022, an estimated $60M.
Frazier Management first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 14 quarters.
Frazier Management's Gritstone bio, Inc. Common Stock position peaked at $60M in Q4 2021.
117 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2022.

Based on Frazier Management's 13F filing for Q1 2022, filed 13 May 2022.